Hemogenyx Pharmaceuticals (HEMO)

Sector:

Pharma and Biotech

1,172.50p
   
  • Change Today:
      92.50p
  • 52 Week High: 1,545.00
  • 52 Week Low: 130.00
  • Currency: UK Pounds
  • Shares Issued: 6.04m
  • Volume: 10,063
  • Market Cap: £70.83m
  • RiskGrade: 340

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Alexis M. Sandler 187,727 £2,201,099
Vladislav Sandler Ph.D. 103,862 £1,217,782
Peter Redmond 13,991 £164,044

Major Shareholders

Notifier** Holding Value*
David John Smith 416,530 £4,883,814
Alexis Sandler 187,726 £2,201,087
Dr Vladislav Sandler 103,862 £1,217,782
Optiva Securities Limited 70,329 £824,608
Flascherberg Capital Anstalt 69,991 £820,644
Craig Auringer 59,593 £698,728
HSBC Client Holdings Nominee (UK) Limited 45,160 £529,501
Ron Valk 42,828 £502,158
Samantha Bauer 42,706 £500,728
Plum Capital 29,232 £342,745
43 North LLC 28,429 £333,330
Abdelatif LACHAB 6,500 £76,212
Wayne Gibson 6,500 £76,212

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

HEMO Market Data

Currency UK Pounds
Share Price 1,172.50p
Change Today 92.50p
% Change 8.56 %
52 Week High 1,545.00
52 Week Low 130.00
Volume 10,063
Shares Issued 6.04m
Market Cap £70.83m
RiskGrade 340

HEMO Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
47% below the market average47% below the market average47% below the market average47% below the market average47% below the market average
56.1% below the sector average56.1% below the sector average56.1% below the sector average56.1% below the sector average56.1% below the sector average
Price Trend
91.8% below the market average91.8% below the market average91.8% below the market average91.8% below the market average91.8% below the market average
90.91% below the sector average90.91% below the sector average90.91% below the sector average90.91% below the sector average90.91% below the sector average
Income Not Available
Growth Not Available

HEMO Dividends

No dividends found

Trades for 26-Feb-2026

Time Volume / Share Price
11:24 1 @ 1,125.00p
11:24 375 @ 1,163.00p
11:22 180 @ 1,220.00p
11:23 42 @ 1,154.10p
11:23 200 @ 1,200.00p

HEMO Key Personnel

CEO Vladislav Sandler Ph.D.

Top of Page